The president announced a major AI investment project, which Oracle Chairman Larry Ellison said could be used to cure cancer.

Investing.com -- Moderna , Inc. (NASDAQ: MRNA) shares surged 14% following remarks by Oracle (NYSE: ORCL) Chairman Larry ...

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...

Members of two Senate committees will have a lot of ground to cover at Robert F. Kennedy Jr.’s confirmation hearing to be ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

An adult human body consists of some 37 trillion cells. Not so long ago, these were thought to come in 220 different types.

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near future ...

A Pseudonym for Protection As a healthcare professional, I write under a pseudonym, not because I want to remain anonymous, ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.